首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
GAS-BLAST LOAD-BREAK SWITCH
摘要
申请公布号
JPH1064378(A)
申请公布日期
1998.03.06
申请号
JP19960221329
申请日期
1996.08.22
申请人
MITSUBISHI ELECTRIC CORP
发明人
MOMOI HITOSHI;KURAGAKI TOSHIHISA
分类号
H01H33/46;(IPC1-7):H01H33/46
主分类号
H01H33/46
代理机构
代理人
主权项
地址
您可能感兴趣的专利
Temperatursensorvorrichtung, Verfahren zum Herstellen einer Temperatursensorvorrichtung und Verwendung einer Temperatursensorvorrichtung
Aufhängegestell für Handwerkzeuge
Absaugvorrichtung für einen Tunnel
FLEXIBLE SUBSTRATE, METHOD FOR MANUFACTURING FLEXIBLE SUBSTRATE, FLEXIBLE DISPLAY DEVICE, AND METHOD FOR FLEXIBLE DISPLAY DEVICE
PAINT COMPOSITION OF SURFACE PROTECTION HAVING FUNCTION OF OZONE RESISTANCE, SURFACE TREATMENT METHOD OF WATER TREATMENT STRUCTURE THEREOF AND ADHESION METHOD OF TILE
BARGE AND BORING EXCAVATION DEVICE SEPARATED MARINE BORING SYSTEM
DESIGN METHOD OF DOOR TRIM SPEAKER GRILL USING FLOW PATTERN ANALYSIS
ROTARY TRANSFER FEEDER
RF power transistor packages with internal harmonic frequency reduction and methods of forming RF power transistor packages with internal harmonic frequency reduction
Pesticidal compositions
AN OPTICAL PROJECTION ARRAY EXPOSURE SYSTEM
Antibody against cytomegalovirus, compositions comprising the same and uses thereof
ANTI-OBESITIC COMPOSITION COMPRISING KIRENOL OR EXTRACT OF SIGESBECKIA ORIENTALIS L.
NONAQUEOUS ELECTROLYTE FOR RECHARGEABLE BATTERY, AND RECHARGEABLE BATTERY WITH NONAQUEOUS ELECTROLYTE
A BUTYRALDEHYDE DEHYDROGENASE MUTANT, A POLYNUCLEOTIDE CODING THE MUTANT, A VECTOR AND A MICROORGANISM HAVING THE POLYNUCLEOTIDE, AND A METHOD OF PRODUCING THE 1,4-BUTANEDIOL USING THE SAME
Baculovirus-derived vector for the expression of p. falciparum antigens
Use of one or more hbv antigens for the preparation of oral pharmaceutical compositions for treating a subject having an active hbv infection or hepatocellular carcinoma
Computer vision based two hand control of content
Use of a naked monovalent class i anti-cea monoclonal antibody or antigen-binding fragment thereof in the preparation of a pharmaceutical composition for treating a cea and/or nca expressing cancer
Use of a salt of bistetrazolylamine